{"id":18290,"date":"2024-07-28T11:38:14","date_gmt":"2024-07-28T08:38:14","guid":{"rendered":"https:\/\/eeca-cat.info\/?p=18290"},"modified":"2025-02-25T11:39:32","modified_gmt":"2025-02-25T08:39:32","slug":"world-hepatitis-day-civil-society-representatives-call-on-who-to-develop-guidelines-for-hepatitis-d-diagnosis-and-treatment","status":"publish","type":"post","link":"https:\/\/eeca-cat.info\/en\/world-hepatitis-day-civil-society-representatives-call-on-who-to-develop-guidelines-for-hepatitis-d-diagnosis-and-treatment\/","title":{"rendered":"World Hepatitis Day: Civil Society Representatives Call on WHO to Develop Guidelines for Hepatitis D Diagnosis and Treatment"},"content":{"rendered":"

Ahead of <\/span>World Hepatitis Day, civil society representatives have sent a letter to the <\/span>World Health Organization (WHO), urging the organization to <\/span>establish a dedicated working group on hepatitis D and develop separate guidelines for its diagnosis and treatment. The <\/span>English version of the letter is available in the attachment.<\/span><\/p>\n

<\/p>\n

The letter was <\/span>initiated by ITPC EECA and ECAT and signed by representatives of <\/span>civil society organizations from EECA countries, as well as international organizations, including <\/span>Treatment Action Group (TAG), GNP+, ITPC Global, and others.<\/span><\/p>\n

According to WHO\u2019s <\/span>2024 report, the <\/span>hepatitis D virus (HDV) affects approximately 5% of people worldwide living with chronic hepatitis B, and <\/span>HDV co-infection accounts for around 20% of liver disease and liver cancer casesamong people with hepatitis B.<\/span><\/p>\n

In recent years, particularly amid the humanitarian crises caused by the <\/span>COVID-19 pandemic and armed conflicts, there has been a <\/span>significant increase in the number of people seeking support from patient organizations and NGOs regarding hepatitis D. Patients report that they are <\/span>unable to receive adequate consultation and medical assistance related to hepatitis D, especially regarding <\/span>diagnosis and treatment. Many individuals seek help <\/span>at late stages of liver damage, which <\/span>complicates treatment and worsens health outcomes. At the same time, <\/span>epidemiological data on hepatitis D remain scarce in both the EECA region and globally, and <\/span>awareness of the issue among healthcare professionals and policymakers remains low.<\/span><\/p>\n

During informal discussions on the importance of a <\/span>dedicated response to hepatitis D, WHO\u2019s <\/span>key role as the leading organization responsible for developing evidence-based guidelines was repeatedly emphasized.<\/span><\/p>\n

Civil society representatives strongly believe that the development of <\/span>new WHO guidelines will <\/span>help improve hepatitis D detection and treatment, raise awareness among healthcare professionals, and ultimately lead to better health outcomes for patients.<\/span><\/p>\n

open_letter_who_hdv_eng<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Ahead of World Hepatitis Day, civil society representatives have sent a letter to the World Health Organization (WHO), urging the organization to establish a dedicated working group on hepatitis D and develop separate guidelines for its diagnosis and treatment. The English version of the letter is available in the attachment.<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[46],"tags":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t